You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 214 No. 10, December 7, 1970 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical and Bacteriological Evaluation of Antibiotic Treatment in Shigellosis

LCDR Myron J. Tong, MC, USNR; LT Donald G. Martin, MSC, USN; LT Jerome J. Cunningham, MC, USNR; CAPT Jean-Jacques Gunning, MC, USN

JAMA. 1970;214(10):1841-1844.


Abstract

Ampicillin trihydrate, administered orally, significantly shortened the duration of diarrhea, abdominal cramps, and fever in 30 adults with shigellosis, when compared to the duration of these symptoms in 30 nontreated controls. Ampicillin also effectively eliminated shigallae from the intestinal tract within 24 to 48 hours of therapy in a majority of cases. In contrast, kanamycin sulfate, given parenterally, was not effective in altering the clinical course, nor in decreasing the number of patients excreting shigellae. Thirty percent (9) of patients treated with ampicillin and 40% (24) in both the kanamycin and control groups continued to shed shigellae 12 days after the start of antibiotic therapy. Although ampicillin therapy effectively shortened the clinical course of shigellosis, further studies are needed to determine whether convalescent excretion of shigellae can be eliminated with either higher doses or a longer course of antibiotic therapy.



Author Affiliations

From the US Naval Medical Research Unit-2 Detachment, Preventive Medicine Unit, and the Department of Medicine, Naval Support Activity Hospital, DaNang, South Vietnam. Drs. Tong and Gunning are now with the US Medical Research Unit No. 2, Taipei, Taiwan, Republic of China; LT Martin is the Laboratory Officer, US Naval Preventive Medicine Unit No. 2, Norfolk, Va; and Dr. Cunningham is with Stanford (Calif) University Medical Center.


Footnotes

The opinions or assertions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the Navy Department or Naval Service at large.

Reprint requests to Publications Editor, NAMRU-2, Box 14, APO San Francisco 96263.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acute Infectious Diarrhea
Thielman and Guerrant
NEJM 2004;350:38-47.
FULL TEXT  

Antimicrobial Resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995
Chu et al.
Antimicrob. Agents Chemother. 1998;42:440-443.
ABSTRACT | FULL TEXT  

Treatment of Shigellosis: III. Comparison of One- or Two-Dose Ciprofloxacin with Standard 5-Day Therapy: A Randomized, Blinded Trial
Bennish et al.
ANN INTERN MED 1992;117:727-734.
ABSTRACT  

Shiga Bacillus Dysentery Acquired in Nicaragua
Counts et al.
Arch Intern Med 1971;128:582-584.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.